LA500 2026: Patrick Soon-Shiong
ImmunityBio’s Stock Sees a Huge Boost
1. Patrick Soon-Shiong
ImmunityBio Wins U.K. Approval
L.A. Times to Go Public, Owner Says
Anktiva Approved For Additional Treatment
LA500 2025: Patrick Soon-Shiong
FDA Delivers Blow to ImmunityBio
2026 State of Business Readiness: Bill Koschak
2026 State of Business Readiness: Steven J. Geller
Philanthropy: Q+A with Gerun Riley
Philanthropy: Q+A with William Ahmanson
Grindr Buys Telehealth Firm in $250M Deal
